Pergamon-Elsevier Science Ltd

SHERPA: Unknown

People

  1. Danishefsky
    Danishefsky
  2. Chiosis
    Chiosis
  3. Rosen
    Rosen
  4. Motzer
    Motzer
  5. Scheinberg
    Scheinberg
  6. Tan
    Tan
  7. Taldone
    Taldone
  8. Ouerfelli
    Ouerfelli
  9. Solit
    Solit
  10. Hudis
    Hudis

Groups

  1. Sloan Kettering Institute Faculty (143)
  2. Molecular Pharmacology and Chemistry Program Faculty (139)
  3. Department of Medicine (75)
  4. GSK Faculty (63)
  5. Solid Tumor Oncology Division (52)
  6. Center for Hematologic Malignancies (32)
  7. Sloan Kettering Institute Postdocs (30)
  8. Hematologic Malignancies Research (25)
  9. Breast Medicine Service (24)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (22)
Search Within
Formats
  1. Journal Article (218)
  2. Meeting Abstract (87)
  3. Book Section (7)
  4. Book Whole (2)
  5. Research Letter (2)
  6. Review (2)
  7. Conference Paper (1)
  8. Editorial (1)
Groups
  1. Sloan Kettering Institute Faculty (143)
  2. Molecular Pharmacology and Chemistry Program Faculty (139)
  3. Department of Medicine (75)
  4. GSK Faculty (63)
  5. Solid Tumor Oncology Division (52)
  6. Center for Hematologic Malignancies (32)

More Groups

People
  1. Samuel Danishefsky (73)
  2. Gavril Pasternak (19)
  3. Gabriela Chiosis (16)
  4. Ting-Chao Chou (16)
  5. Huajin Dong (10)
  6. Neal Rosen (10)

More People

Years
  1. 2024 (8)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. EJC Supplements (82)
  2. Tetrahedron Letters (75)
  3. Bioorganic & Medicinal Chemistry Letters (27)
  4. Bioorganic & Medicinal Chemistry (24)
  5. Molecular Immunology (20)
  6. Neuropharmacology (15)

More Publications

Results (320)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Syntheses of isomerically pure reference octalins and hydrindanes
    Journal Article

    Lee, J. H.; Kim, W. H.; Danishefsky, S. J.
    Tetrahedron Letters (2009)

    Fulltext@MSK | Save
  • 'Biologic' level structures through chemistry: a total synthesis of a unimolecular pentavalent MUCI glycopeptide construct
    Journal Article

    Lee, D.; Danishefsky, S. J.
    Tetrahedron Letters (2009)

    Fulltext@MSK | Save
  • Novel DNA-directed alkylating agents: Design, synthesis and potent antitumor effect of phenyl N-mustard-9-anilinoacridine conjugates via a carbamate or carbonate linker
    Journal Article

    Kapuriya, N.; Kapuriya, K.; Dong, H.; Zhang, X.; Chou, T. C.; Chen, Y. T.; Lee, T. C.; Lee, W. C.; Tsai, T. H.; Naliapara, Y.; more...
    Bioorganic & Medicinal Chemistry (2009)

    Fulltext@MSK | Save
  • Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes
    Journal Article

    Kakadiya, R.; Dong, H.; Lee, P. C.; Kapuriya, N.; Zhang, X.; Chou, T. C.; Lee, T. C.; Kapuriya, K.; Shah, A.; Su, T. L.
    Bioorganic & Medicinal Chemistry (2009)

    Fulltext@MSK | Save
  • An oxidative dearomatization cyclization model for cortistatin A
    Journal Article

    Dai, M.; Danishefsky, S. J.
    Heterocycles (2009)

    Fulltext@MSK | Save
  • Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: Toward selective Abl inhibitors
    Journal Article

    Antczak, C.; Veach, D. R.; Ramirez, C. N.; Minchenko, M. A.; Shum, D.; Calder, P. A.; Frattini, M. G.; Clarkson, B.; Djaballah, H.
    Bioorganic & Medicinal Chemistry Letters (2009)

    Fulltext@MSK | Save
  • Phase I study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in patients with advanced malignancies
    Meeting Abstract

    Tse, A.; Yazji, S.; Naing, A.; Matthews, D.; Schwartz, G.; Lawhorn, K.; Kurzrock, R.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Apoptosis imaging
    Meeting Abstract

    Strauss, H.; Blankenberg, F.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Potent anticancer activity of panobinostat (LBH589) in models of hormone-refractory prostate cancer (HRPC): Targeting the androgen receptor
    Meeting Abstract

    Shao, W.; Growney, J.; O'Connor, G.; Feng, Y.; Scher, H.; Yao, Y. M.; Fawell, S.; Atadja, P.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Nanoparticle albumin-bound paclitaxel in 3 dosing schedules with bevacizumab as first line therapy for HER2-negative metastatic breast cancer: An interim safety analysis
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Moynahan, M. E.; Bach, A.; Troso-Sandoval, T.; Sugarman, S.; Forero, A.; Kerr, R.; Wright, G.; Hudis, C. A.
    EJC Supplements (2008)

    Fulltext@MSK | Save